The Ophthalmology DEQ 5 Test: A Game-Changer for Patient Care

The Ophthalmology Dry Eye Questionnaire (DEQ) 5 Test is a cornerstone in diagnosing and managing dry eye disease. This condition significantly impacts patient quality of life, leading to discomfort, vision impairment, and reduced productivity. Early detection and intervention are crucial to preventing disease progression and complications.

The Silent Epidemic: The Growing Burden of Dry Eye Disease

Dry eye disease is a prevalent condition affecting millions worldwide. The condition often goes undiagnosed or undertreated, leading to a cascade of issues, including chronic inflammation, corneal damage, and potential vision loss. The economic burden of dry eye disease is substantial, encompassing healthcare costs, lost productivity, and reduced quality of life.

Kribado: Your Partner in Patient Care

Kribado is a cutting-edge risk stratification and behavior setting device designed to revolutionize patient care. By utilizing the Ophthalmology DEQ 5 Test and other relevant COAs, Kribado empowers healthcare providers to identify patients at risk for dry eye disease and other ocular conditions early on.

This non-invasive screening tool instantly provides a risk score, enabling efficient patient triage and targeted interventions. Kribado’s user-friendly interface and accurate data collection eliminate errors and improve overall efficiency.

Indigital Technologies: Your Trusted Partner

Indigital Technologies is a leading provider of innovative healthcare solutions. With over nine years of experience and a proven track record of success, we have partnered with 653 pharmaceutical brands across 8 countries to generate over 9700 crores in revenue.

Our commitment to excellence is reflected in our three patents and our exceptional customer satisfaction rating of 4.2 stars. Kribado is a testament to our dedication to advancing patient care.